相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeting RET to induce medullary thyroid cancer cell apoptosis: an antagonistic interplay between PI3K/Akt and p38MAPK/caspase-8 pathways
Minakshi Mazumdar et al.
APOPTOSIS (2013)
Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway
Weiming Duan et al.
JOURNAL OF RADIATION RESEARCH (2013)
Tumor suppressor genes and ROS: complex networks of interactions
Beyza Vurusaner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and-103, Target the Differentiation Inhibitor ID2
Daniela Annibali et al.
PLOS ONE (2012)
The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non-Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts
Motonobu Saito et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma
Nannan Wu et al.
FEBS JOURNAL (2011)
Identification of MiR-374a as a Prognostic Marker for Survival in Patients with Early-Stage Nonsmall Cell Lung Cancer
Urmo Vosa et al.
GENES CHROMOSOMES & CANCER (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
Shyamal D. Weeraratne et al.
NEURO-ONCOLOGY (2011)
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
G. Mudduluru et al.
ONCOGENE (2011)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk
Arghya Adhikary et al.
FEBS LETTERS (2010)
Selective induction of catalase-mediated autophagy by dihydrocapsaicin in lung cell lines
Cheol-Hee Choi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Capsaicin: A novel chemopreventive molecule and its underlying molecular mechanisms of action
A. A. Oyagbemi et al.
INDIAN JOURNAL OF CANCER (2010)
Capsaicin Displays Anti-Proliferative Activity against Human Small Cell Lung Cancer in Cell Culture and Nude Mice Models via the E2F Pathway
Kathleen C. Brown et al.
PLOS ONE (2010)
MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
Yunqing Li et al.
CANCER RESEARCH (2009)
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Elena Gallardo et al.
CARCINOGENESIS (2009)
MiR-34, SIRT1 and p53 The feedback loop
Munekazu Yamakuchi et al.
CELL CYCLE (2009)
Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis
Lakshmishri Lahiry et al.
APOPTOSIS (2008)
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Dmitri Lodygin et al.
CELL CYCLE (2008)
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest
Fang Sun et al.
FEBS LETTERS (2008)
ROS and p53: A versatile partnership
Bin Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
The MYCN oncogene is a direct target of miR-34a
J. S. Wei et al.
ONCOGENE (2008)
The guardian's little helper: MicroRNAs in the p53 tumor suppressor network
Xingyue He et al.
CANCER RESEARCH (2007)
Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation
Ana Maria Sanchez et al.
APOPTOSIS (2007)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction
Sankar Bhattacharyya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death
Andriani Athanasiou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Black tea-induced amelioration of hepatic oxidative stress through antioxidative activity in EAC-bearing mice
Arindam Bhattacharyya et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2007)
Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells
A Mori et al.
CANCER RESEARCH (2006)
DNA damage-induced cell death by apoptosis
Wynand P. Roos et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Does γH2AX foci formation depend on the presence of DNA double strand breaks?
A Takahashi et al.
CANCER LETTERS (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner
T Choudhuri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: Implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species
K Ito et al.
CANCER RESEARCH (2004)
Genotoxicity studies with pure trans-capsaicin
S Chanda et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2004)
Phosphorylation site interdependence of human p53 post-translational modifications in response to stress
S Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Post-translational modifications and activation of p53 by genotoxic stresses
E Appella et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation
MY Jung et al.
CANCER LETTERS (2001)